Calumet, Inc. (NASDAQ:CLMT) Director Sells $1,623,000.00 in Stock

Calumet, Inc. (NASDAQ:CLMT) Director Jennifer Straumins sold 100,000 shares of Calumet stock in a transaction that occurred on Monday, June 16th. The shares were sold at an average price of $16.23, for a total transaction of $1,623,000.00. Following the transaction, the director now directly owns 934,589 shares in the company, valued at approximately $15,168,379.47. The trade was a 9.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Jennifer Straumins also recently made the following trade(s):

• On Friday, June 13th, Jennifer Straumins sold 50,000 shares of Calumet stock. The shares were sold at an average price of $15.08, for a total value of $754,000.00.
• On Thursday, June 5th, Jennifer Straumins sold 100,000 shares of Calumet stock. The stock was sold at an average price of $13.17, for a total value of $1,317,000.00.

Calumet Stock Performance

Calumet stock opened at $16.88 on Wednesday. The stock has a market cap of $1.46 billion, a PE ratio of -4.22 and a beta of 0.91. The stock has a 50-day moving average of $12.38 and a two-hundred day moving average of $15.24. Calumet, Inc. has a one year low of $7.68 and a one year high of $25.29.

Calumet (NASDAQ:CLMT) last posted its quarterly earnings data on Friday, May 9th. The oil and gas company reported ($1.03) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.41) by ($0.62). The firm had revenue of $993.90 million for the quarter, compared to analysts’ expectations of $899.62 million. The firm’s quarterly revenue was down 1.2% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.51) EPS. As a group, sell-side analysts predict that Calumet, Inc. will post -3.02 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the company. Bank of America initiated coverage on Calumet in a research report on Tuesday, May 13th. They set a “buy” rating and a $15.00 price objective on the stock. UBS Group raised shares of Calumet from a “sell” rating to a “neutral” rating and decreased their price target for the company from $15.00 to $12.00 in a research report on Monday, March 17th. Wells Fargo & Company lowered their price target on shares of Calumet from $23.00 to $21.00 and set an “overweight” rating on the stock in a report on Wednesday, May 14th. HC Wainwright reaffirmed a “buy” rating and issued a $33.00 price objective on shares of Calumet in a research report on Monday, March 3rd. Finally, The Goldman Sachs Group decreased their target price on shares of Calumet from $16.00 to $14.00 and set a “buy” rating for the company in a research report on Wednesday, April 30th. One analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $18.50.

About Calumet

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.